|
Title: |
Is There a Need for Positron Emission Tomography Imaging to
Stage the N0 Neck in T1-T2 Squamous Cell Carcinoma of the
Oral Cavity or Oropharynx? |
| Authors: |
Ursula Schroeder, MD; Markus Dietlein, MD; Claus Wittekindt, MD;
Monika Ortmann, MD; Hartmut Stuetzer, MD; Julia Vent, MD;
Markus Jungehuelsing, MD; Barbara Krug, MD |
| |
Objectives: We assess whether negative findings on computed tomography (CT), magnetic resonance imaging (MRI),
and/or 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) may contribute to the decision-making process
of elective neck dissection (eND) in patients with squamous cell carcinoma of the oral cavity or the oropharynx
(oSCC) staged cT1-T2 cN0 cM0.
Methods: We interpreted CT, MRI, and 18FDG-PET images separately, after combining the data of CT with those of
18FDG-PET and the data of MRI with those of 18FDG-PET. Each set of results was then compared with the histopathologic
results of ipsilateral or bilateral eND in a prospective, blinded study.
Results: The histopathologic examination of 594 lymph nodes revealed 4 metastases less than 4 mm in diameter and 3
micrometastases (less than 2 mm) in 6 of 17 patients. On CT, MRI, and 18FDG-PET, respectively, 5, 5, and 0 cases were
true-malignant (true positives) and 4, 10, and 1 cases were false-malignant (false positives). The accuracy was not enhanced
by fusing CT with 18FDG-PET or MRI with 18FDG-PET.
Conclusions: The detectability threshold of occult metastases appears to be below the spatial and contrast resolution of
CT, MRI, and 18FDG-PET. The decision for eND in patients with cT1-T2 cN0 cM0 oSCC cannot be based upon crosssectional
imaging at the resolutions currently available. (Ann Otol Rhinol Laryngol 2008;117:854-863.) |
| Keywords: |
elective neck dissection, fluorodeoxyglucose positron emission tomography, head and neck squamous cell
carcinoma, imaging, occult metastasis |
| |
|
| |
Acrobat Reader 8.0 is recommeded to properly view and print the article.
Reader can be downloaded here:

|